Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

MGMA outlines path and pitfalls in CMS 2030 value-based care push
The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.
FDA approves JenaValve TAVR system for aortic regurgitation
The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.
Bipartisan bill would exempt radiologists from new $100,000 visa fee
The bill is endorsed by the American Medical Association, American Hospital Association and numerous others in the industry.
Insurer and business lobbying interests kill supplemental breast imaging bill in 1 state
Earlier this year, Kansas lawmakers introduced Senate Bill 409, seeking to close insurance gaps for women who need follow-up scans after screening mammography.
ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations
Judge Brian Murphy with the U.S. District Court of Massachusetts sided with the American Academy of Pediatrics and other plaintiffs who challenged the authority of HHS Secretary Robert F. Kennedy Jr to effectively remove the Advisory Committee on Immunization Practices from the process put in place to make changes to CDC vaccine recommendations.

Video interview with Anders Gilberg, MGA, senior vice president, government affairs at Medical Group Management Association (MGMA), explains various value-based payment models the Centers for Medicare and Medicaid Services (CMS) is experimenting with, but notes out or more than 30 models, only two have actually saved Medicare money.

MGMA outlines path and pitfalls in CMS 2030 value-based care push

The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.

FDA approves JenaValve TAVR system for aortic regurgitation

The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.

Bipartisan bill would exempt radiologists from new $100,000 visa fee

The bill is endorsed by the American Medical Association, American Hospital Association and numerous others in the industry.

Insurer and business lobbying interests kill supplemental breast imaging bill in 1 state

Earlier this year, Kansas lawmakers introduced Senate Bill 409, seeking to close insurance gaps for women who need follow-up scans after screening mammography.

ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations

Judge Brian Murphy with the U.S. District Court of Massachusetts sided with the American Academy of Pediatrics and other plaintiffs who challenged the authority of HHS Secretary Robert F. Kennedy Jr to effectively remove the Advisory Committee on Immunization Practices from the process put in place to make changes to CDC vaccine recommendations.

'Cybersecurity vulnerability' spurs FDA recall of GE HealthCare image viewers

The recall is due to an issue with the software that could make the viewer vulnerable to security threats and data manipulation.

Radiologists support bipartisan bill to fund new residency programs in rural areas

The American College of Radiology, alongside over 30 other organizations, voiced “strong support” for the bill on March 16.

stroke brain dementia alzheimer's puzzle mental health

Telix submits new brain imaging agent for FDA review following previous rejection

The Australia-based company has resubmitted its New Drug Application for Pixclara, an investigational PET product.